ZA200006300B - Composition comprising tumor cells and extracts and method of using thereof. - Google Patents

Composition comprising tumor cells and extracts and method of using thereof.

Info

Publication number
ZA200006300B
ZA200006300B ZA200006300A ZA200006300A ZA200006300B ZA 200006300 B ZA200006300 B ZA 200006300B ZA 200006300 A ZA200006300 A ZA 200006300A ZA 200006300 A ZA200006300 A ZA 200006300A ZA 200006300 B ZA200006300 B ZA 200006300B
Authority
ZA
South Africa
Prior art keywords
extracts
composition
tumor cells
tumor
cells
Prior art date
Application number
ZA200006300A
Other languages
English (en)
Inventor
David Berd
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of ZA200006300B publication Critical patent/ZA200006300B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200006300A 1998-05-04 2000-11-03 Composition comprising tumor cells and extracts and method of using thereof. ZA200006300B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8408198P 1998-05-04 1998-05-04

Publications (1)

Publication Number Publication Date
ZA200006300B true ZA200006300B (en) 2001-06-07

Family

ID=22182777

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200006300A ZA200006300B (en) 1998-05-04 2000-11-03 Composition comprising tumor cells and extracts and method of using thereof.

Country Status (16)

Country Link
US (2) US6458369B1 (ko)
EP (1) EP1082134B1 (ko)
JP (1) JP2002513772A (ko)
KR (1) KR20010043331A (ko)
CN (1) CN1309569A (ko)
AR (1) AR016254A1 (ko)
AT (1) ATE401096T1 (ko)
AU (1) AU3786999A (ko)
BR (1) BR9910187A (ko)
CA (1) CA2328507A1 (ko)
DE (1) DE69939111D1 (ko)
ES (1) ES2311303T3 (ko)
IL (1) IL139442A0 (ko)
PL (1) PL347981A1 (ko)
WO (1) WO1999056773A2 (ko)
ZA (1) ZA200006300B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009140A1 (en) * 1997-07-24 2000-02-24 Thomas Jefferson University Composition and method of using tumor cells
CN1309569A (zh) * 1998-05-04 2001-08-22 托马斯杰斐逊大学 含有肿瘤细胞和提取物的组合物及其使用方法
ATE255420T1 (de) * 1998-09-25 2003-12-15 Horst Lindhofer Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
US6248585B1 (en) 1998-11-19 2001-06-19 Thomas Jefferson University Compositions for preserving haptenized tumor cells for use in vaccines
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
JP2004507446A (ja) * 2000-02-04 2004-03-11 トーマス・ジェファーソン・ユニバーシティ 低用量ハプテン化腫瘍細胞および腫瘍細胞抽出物の免疫治療
EP1480660A4 (en) * 2002-02-01 2008-02-20 Univ Jefferson MIXTURES OF HAPTENIZED TUMOR CELLS AND EXTRACTS THEREOF AND METHODS OF TREATING OR SCREENING CANCER
AU2003243485A1 (en) 2002-06-10 2003-12-22 Avax Technologies Inc. Cryopreservation of haptenized tumor cells
CA2593191A1 (en) * 2005-01-14 2006-07-20 Avax Technologies, Inc. Method for producing a vaccine for the treatment of cancer
WO2010002983A2 (en) * 2008-07-03 2010-01-07 Duke University Composition and methods for eliciting an immune response
TWI540816B (zh) 2014-03-10 2016-07-01 新唐科技股份有限公司 切換電路及馬達能源回收系統
JP6767096B2 (ja) 2014-12-11 2020-10-14 リティックス バイオファーマ エイエス 免疫チェックポイント阻害剤の組み合わせ
JP6813258B2 (ja) 2014-12-11 2021-01-13 リティックス バイオファーマ エイエス 化学療法の組み合わせ
AU2019346403A1 (en) * 2018-09-24 2021-04-29 BioVaxys Inc. Bihaptenized autologous vaccines and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020004052A1 (en) * 1990-05-08 2002-01-10 David Berd Composition comprising a tumor cell extract and method of using the composition
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
US5478556A (en) * 1994-02-28 1995-12-26 Elliott; Robert L. Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor
BR9609026A (pt) 1995-06-07 1999-07-06 Univ Jefferson Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos
PL328790A1 (en) * 1996-10-04 1999-02-15 Univ Jefferson T-lymphocytes provoking an immunological response and methods of using them
CN1309569A (zh) * 1998-05-04 2001-08-22 托马斯杰斐逊大学 含有肿瘤细胞和提取物的组合物及其使用方法

Also Published As

Publication number Publication date
EP1082134A2 (en) 2001-03-14
CA2328507A1 (en) 1999-11-11
WO1999056773A2 (en) 1999-11-11
EP1082134B1 (en) 2008-07-16
WO1999056773A9 (en) 2000-03-23
DE69939111D1 (de) 2008-08-28
CN1309569A (zh) 2001-08-22
AU3786999A (en) 1999-11-23
ES2311303T3 (es) 2009-02-01
US6458369B1 (en) 2002-10-01
BR9910187A (pt) 2002-01-29
JP2002513772A (ja) 2002-05-14
WO1999056773A3 (en) 2000-01-20
KR20010043331A (ko) 2001-05-25
ATE401096T1 (de) 2008-08-15
PL347981A1 (en) 2002-05-06
AR016254A1 (es) 2001-06-20
IL139442A0 (en) 2001-11-25
US20030068337A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
EP1119365A4 (en) COMPOSITIONS AND METHODS FOR USING TUMOR CELLS
AU4701899A (en) Herbal extract composition and method with immune-boosting capability
PL348457A1 (en) High water content dentifrice composition and method of making the same
ZA989400B (en) Method and composition
AU5336499A (en) Composition and method of treating disease with extract of (musaceas)
PH31270A (en) Superplasticizer-concrete composition and method of preparation.
ZA200006300B (en) Composition comprising tumor cells and extracts and method of using thereof.
EP1100136A4 (en) CELL AND METHOD FOR THE PRODUCTION THEREOF
ZA989207B (en) Method of building and maintaining bone.
GB2346823B (en) Reamer and method of using the same
GB9803506D0 (en) Composition and method
AU3204899A (en) Hair treatment composition and method
PL342453A1 (en) Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs
AU2113799A (en) Multiple pocket envelope and method of making
PL325142A1 (en) Novel compounds-derivatives of benzoxazinodione, method of obtaining them and their application
EP1066311A4 (en) COMPOSITIONS AND METHODS FOR IDENTIFYING LUNG TUMOR CELLS
GB9807586D0 (en) Enzymes and their use
IL141315A0 (en) Composition and method of using tumor cells
EP1073332A4 (en) R-RABEPRAZOL COMPOSITIONS AND METHODS
GB9821177D0 (en) Applicator and method
ZA995262B (en) Massage composition and method.
MXPA00006072A (es) Metodos y composiciones para inhibir el crecimiento de celulas tumorales.
ZA9811960B (en) Salicylaldoximes and method of preparation.
AU1776899A (en) Salicylaldoximes and method of preparation
PL341763A1 (en) Triazepinones, method of obtaining them and their therapeutic application